MoLEP-Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania. [PDF]
Barth-Jaeggi T +11 more
europepmc +1 more source
Case Report: Recurrent Type 2 Leprosy Reaction Associated with Multiple Nerve Function Impairments Refractory to Steroids: A Therapeutic Challenge. [PDF]
Khurana A +4 more
europepmc +1 more source
Leprosy in French Guiana, 2015 to 2021: Dynamics of a Persistent Public Health Problem. [PDF]
Petiot A +4 more
europepmc +1 more source
Challenges of the public health response to a rare case of non-autochthonous <i>Mycobacterium leprae</i>, Ireland, 2024. [PDF]
Marshall R +9 more
europepmc +1 more source
Leprosy in the 21st century: a comprehensive review of immunological mechanisms, diagnosis, and treatment. [PDF]
Froes Junior LAR +2 more
europepmc +1 more source
Clinical-epidemiological profile of leprosy patients undergoing retreatment at a reference center in southeastern Brazil. [PDF]
Bezerra GH +2 more
europepmc +1 more source
Case of leprosy mimicking preseptal cellulitis: a diagnostic dilemma. [PDF]
Sarkar D, Chawla H, Singh P, Verma V.
europepmc +1 more source
Case Report: Nonalcoholic Hepatic Steatosis Associated with Type-2 Leprosy Reaction. [PDF]
Araujo Orozco KL +4 more
europepmc +1 more source
An Unusual Case of Hyperpigmented Maculopapular Rash with Unmasking of Lepromatous Leprosy after Steroid Cessation. [PDF]
Hassan S, Rathish B, Mukthar F.
europepmc +1 more source
Global leprosy scenario: Eradication, elimination or control? [PDF]
Gupte M.
europepmc +1 more source

